Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer
Clin Lung Cancer
.
2024 Dec;25(8):e482-e486.e3.
doi: 10.1016/j.cllc.2024.08.016.
Epub 2024 Sep 3.
Authors
May-Lucie Meyer
1
,
Louis Gros
2
,
Natalie Décosterd
3
,
Marco Tagliamento
4
,
Arianna Marinello
5
,
David Planchard
5
,
David Combarel
4
,
Fabrice Barlesi
5
,
Jordi Remon
4
,
Benjamin Besse
5
,
Mihaela Aldea
6
Affiliations
1
Gustave Roussy Cancer Center, illejuif, France; Tisch Cancer institute, Mount Sinai, New York, NY.
2
Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place New York, NY.
3
Gastroenterology, CHUV, Lausanne Universitary Hospital, Lausanne, Switzerland.
4
Gustave Roussy Cancer Center, illejuif, France.
5
Gustave Roussy Cancer Center, illejuif, France; Paris-Saclay University, Le Kremlin-Bicêtre, France.
6
Gustave Roussy Cancer Center, illejuif, France; Paris-Saclay University, Le Kremlin-Bicêtre, France. Electronic address:
[email protected]
.
PMID:
39332921
DOI:
10.1016/j.cllc.2024.08.016
No abstract available
Keywords:
Amylase; Lipase; NSCLC; Targeted therapy; Toxicity.
Publication types
Case Reports